Published in J Immunol on April 15, 2001
Trogocytosis-based generation of suppressive NK cells. EMBO J (2007) 1.40
HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics (2003) 1.38
Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production. Am J Pathol (2001) 1.35
HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells. Proc Natl Acad Sci U S A (2004) 1.34
Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism. Proc Natl Acad Sci U S A (2001) 1.32
Annexin II incorporated into influenza virus particles supports virus replication by converting plasminogen into plasmin. J Virol (2008) 1.23
The stem cell secretome and its role in brain repair. Biochimie (2013) 1.19
KIR2DL4 (CD158d): An activation receptor for HLA-G. Front Immunol (2012) 1.10
NKG2D ligand MICA is retained in the cis-Golgi apparatus by human cytomegalovirus protein UL142. J Virol (2009) 1.09
HLA-F is a surface marker on activated lymphocytes. Eur J Immunol (2010) 1.03
Natural killer cell killing of acute myelogenous leukemia and acute lymphoblastic leukemia blasts by killer cell immunoglobulin-like receptor-negative natural killer cells after NKG2A and LIR-1 blockade. Biol Blood Marrow Transplant (2010) 1.00
The role of HLA-G in human pregnancy. Reprod Biol Endocrinol (2006) 0.95
The role of HLA-G in immunity and hematopoiesis. Cell Mol Life Sci (2010) 0.88
Roles for major histocompatibility complex glycosylation in immune function. Semin Immunopathol (2012) 0.88
Synthetic HLA-G proteins for therapeutic use in transplantation. FASEB J (2013) 0.87
A novel mechanism of soluble HLA-G mediated immune modulation: downregulation of T cell chemokine receptor expression and impairment of chemotaxis. PLoS One (2010) 0.86
A specific immune transcriptomic profile discriminates chronic kidney disease patients in predialysis from hemodialyzed patients. BMC Med Genomics (2013) 0.86
Multimeric structures of HLA-G isoforms function through differential binding to LILRB receptors. Cell Mol Life Sci (2012) 0.85
The paradox of IL-10-mediated modulation in cervical cancer. Biomed Rep (2013) 0.85
HLA-G as a tolerogenic molecule in transplantation and pregnancy. J Immunol Res (2014) 0.85
Interactions between HLA-G and HLA-E in Physiological and Pathological Conditions. Front Immunol (2014) 0.84
Placental abruption is associated with decreased maternal plasma levels of soluble HLA-G. J Clin Immunol (2003) 0.84
Tolerogenic function of dimeric forms of HLA-G recombinant proteins: a comparative study in vivo. PLoS One (2011) 0.83
Nitric oxide produces HLA-G nitration and induces metalloprotease-dependent shedding creating a tolerogenic milieu. Immunology (2008) 0.82
Cornea: Window to Ocular Immunology. Curr Immunol Rev (2011) 0.81
HLA Class Ib Molecules and Immune Cells in Pregnancy and Preeclampsia. Front Immunol (2014) 0.81
HLA-G expression on blasts and tolerogenic cells in patients affected by acute myeloid leukemia. J Immunol Res (2014) 0.81
The many faces of human leukocyte antigen-G: relevance to the fate of pregnancy. J Immunol Res (2014) 0.80
Indoleamine 2,3 dioxygenase and human leucocyte antigen-G inhibit the T-cell alloproliferative response through two independent pathways. Immunology (2005) 0.80
Some basic aspects of HLA-G biology. J Immunol Res (2014) 0.80
Human leukocyte antigen-G expression in differentiated human airway epithelial cells: lack of modulation by Th2-associated cytokines. Respir Res (2013) 0.79
Identification and characterization of an alternatively spliced variant of the MHC class I-related porcine neonatal Fc receptor for IgG. Dev Comp Immunol (2008) 0.79
Herpes B virus, macacine herpesvirus 1, breaks simplex virus tradition via major histocompatibility complex class I expression in cells from human and macaque hosts. J Virol (2012) 0.79
The role of Qa-2, the functional homolog of HLA-G, in a Behcet's disease-like mouse model induced by the herpes virus simplex. J Inflamm (Lond) (2010) 0.77
Non-classical MHC-E (Mamu-E) expression in the rhesus monkey placenta. Placenta (2007) 0.76
Targeting Ewing sarcoma with activated and GD2-specific chimeric antigen receptor-engineered human NK cells induces upregulation of immune-inhibitory HLA-G. Oncoimmunology (2016) 0.76
Impact of the NK cell receptor LIR-1 (ILT-2/CD85j/LILRB1) on cytotoxicity against multiple myeloma. Clin Dev Immunol (2012) 0.76
Characterization of cynomolgus and vervet monkey placental MHC class I expression: diversity of the nonhuman primate AG locus. Immunogenetics (2009) 0.76
Transcriptomics: A Step behind the Comprehension of the Polygenic Influence on Oxidative Stress, Immune Deregulation, and Mitochondrial Dysfunction in Chronic Kidney Disease. Biomed Res Int (2016) 0.75
Dynamic expression of Qa-2 during acute graft rejection. Mol Med (2010) 0.75
Bronchial Epithelial Cells from Asthmatic Patients Display Less Functional HLA-G Isoform Expression. Front Immunol (2017) 0.75
Increase in concentration of soluble HLA-G in high-quality embryos after intracytoplasmic sperm injection. Anat Cell Biol (2011) 0.75
Association of HLA-A and Non-Classical HLA Class I Alleles. PLoS One (2016) 0.75
Effect of extreme conditions of Antarctica on human leukocyte antigen-G in Indian expeditioners. Indian J Med Res (2014) 0.75
HLA-G does not have a pathophysiological role in Graves' disease. J Clin Pathol (2003) 0.75
Impact of HLA-G in the outcome of vitiligo in Tunisian patients. Indian J Dermatol (2010) 0.75
Association of soluble HLA-G with acute rejection episodes and early development of bronchiolitis obliterans in lung transplantation. PLoS One (2014) 0.75
cFLIP expression is altered in severe corticosteroid-resistant asthma. Genom Data (2014) 0.75
β Cells that Resist Immunological Attack Develop during Progression of Autoimmune Diabetes in NOD Mice. Cell Metab (2017) 0.75
Trogocytic intercellular membrane exchanges among hematological tumors. J Hematol Oncol (2015) 0.75
Molecular characterization of MHC class II in the Australian invasive cane toad reveals multiple splice variants. Immunogenetics (2016) 0.75
Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells. Blood (1997) 3.56
Construction and characterization of a yeast artificial chromosome library containing seven haploid human genome equivalents. Proc Natl Acad Sci U S A (1990) 3.09
Antibody-induced redistribution of HL-A antigens at the cell surface. Eur J Immunol (1972) 2.58
Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci U S A (1997) 2.14
Non-isotopic and sensitive method for diagnosis of maternally-inherited diabetes and deafness. Diabetologia (1994) 2.03
[The Center for the Study of Human Polymorphism]. Presse Med (1986) 1.94
Genetics of HLA disease association. Annu Rev Genet (1981) 1.74
Clinicoepidemiological profile and predictors of severe illness in young infants (< 60 days) reporting to a hospital in North India. Indian Pediatr (2007) 1.72
The major histocompatibility complex in man. Science (1981) 1.72
A systematic study of HLA class II-beta DNA restriction fragments in insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A (1985) 1.69
A comparison of concurrent and retrospective verbal protocol analysis. Am J Psychol (2000) 1.67
HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance. Proc Natl Acad Sci U S A (1998) 1.63
Some chronic lymphocytic leukemia cells bearing surface immunoglobulins share determinants with T cells. Eur J Immunol (1978) 1.58
Expanded polyglutamines in Caenorhabditis elegans cause axonal abnormalities and severe dysfunction of PLM mechanosensory neurons without cell death. Proc Natl Acad Sci U S A (2001) 1.53
Class II HLA-DC beta-chain DNA restriction fragments differentiate among HLA-DR2 individuals in insulin-dependent diabetes and multiple sclerosis. Proc Natl Acad Sci U S A (1984) 1.52
The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis. Proc Natl Acad Sci U S A (2001) 1.51
An antigen shared by a human T cell subset and B cell chronic lymphocytic leukemic cells. Distribution on normal and malignant lymphoid cells. J Exp Med (1980) 1.50
Plasma acetate turnover and oxidation. J Clin Invest (1979) 1.47
IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes. Int Immunol (1999) 1.46
Analysis of 221 renal transplants: influence of cross-reactions between donor and recipient HL-A antigens. Transplant Proc (1971) 1.45
The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors? Proc Natl Acad Sci U S A (1997) 1.44
SIAH-1 promotes apoptosis and tumor suppression through a network involving the regulation of protein folding, unfolding, and trafficking: identification of common effectors with p53 and p21(Waf1). Proc Natl Acad Sci U S A (1999) 1.44
Inhibition of presenilin 1 expression is promoted by p53 and p21WAF-1 and results in apoptosis and tumor suppression. Nat Med (1998) 1.44
Altered glucose metabolism in metastatic carcinoma. Cancer Res (1975) 1.43
HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes. Int Immunol (1999) 1.41
Activation of the human homologue of the Drosophila sina gene in apoptosis and tumor suppression. Proc Natl Acad Sci U S A (1996) 1.40
Spontaneous retinopathy in HLA-A29 transgenic mice. Proc Natl Acad Sci U S A (2001) 1.38
HLA-and Gm-linked genes affecting the degradation rate of antigens (sheep red blood cells) endocytized by macrophages. Hum Immunol (1982) 1.37
Glycerol turnover and oxidation in man. J Clin Invest (1972) 1.35
A haplotype study of HLA complex with special reference to the HLA-DR series and to Bf. C2 and glyoxalase I polymorphisms. Tissue Antigens (1978) 1.35
The association of the HL-A antigens with diseases. Clin Immunol Immunopathol (1974) 1.34
Polymorphic restriction endonuclease fragment segregates and correlates with the gene for HLA-B8. Proc Natl Acad Sci U S A (1983) 1.33
Clusters of HLA class II beta restriction fragments describe allelic series. Proc Natl Acad Sci U S A (1984) 1.32
Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism. Proc Natl Acad Sci U S A (2001) 1.32
A study of HL-A antigens in human organs. Transplantation (1970) 1.32
The relation of parental sex and age to recombination in the HL-A system. Hum Hered (1973) 1.30
Human T cell gamma genes are frequently rearranged in B-lineage acute lymphoblastic leukemias but not in chronic B cell proliferations. J Exp Med (1987) 1.28
The HL-A system sub-loci and their importance in transplantation. Transplant Proc (1969) 1.27
Accelerated telomere shortening and telomerase activation in Fanconi's anaemia. Br J Haematol (1999) 1.26
Ranks of donor-recipient histocompatibility for human transplantation. Science (1970) 1.24
An alternatively spliced form of HLA-G mRNA in human trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes. Proc Natl Acad Sci U S A (1994) 1.23
Use of the Auto-Analyzer to perform serological tests for syphilis. Study of 1,009 sera using a complement fixation test with the cardiolipidic antigen. Int Arch Allergy Appl Immunol (1967) 1.23
APC genotype, polyp number, and surgical options in familial adenomatous polyposis. Ann Surg (1998) 1.22
Oxidation of plasma FFA in lean and obese humans. Metabolism (1968) 1.22
Serologic factors in human transplantation. Ann Surg (1967) 1.22
Plasma acetone metabolism in the fasting human. J Clin Invest (1979) 1.21
Turnover rate of plasma FFA in humans and in dogs. Metabolism (1967) 1.21
HLA haplotype study of 53 juvenile insulin-dependent diabetic (I.D.D.) families. Tissue Antigens (1982) 1.19
Theoretical analysis of a physical mapping strategy using random single-copy landmarks. Proc Natl Acad Sci U S A (1991) 1.19
Improved control of partial DNA restriction enzyme digest in agarose using limiting concentrations of Mg++. Nucleic Acids Res (1989) 1.18
Biology and functions of human leukocyte antigen-G in health and sickness. Tissue Antigens (2003) 1.18
Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells. Hum Immunol (2000) 1.18
Immunoferritin study of the distribution of HL-A antigens on human blood cells. J Immunol (1971) 1.17
Human transplantation antigens: the HL-A (Hu-1) system and its homology with the mouse H-2 system. Transplantation (1968) 1.17
HLA-G inhibits the allogeneic proliferative response. J Reprod Immunol (1999) 1.16
Critical evaluation of histocompatibility in 179 renal transplants. Lancet (1971) 1.16
Activation of p53 transcriptional activity requires ATM's kinase domain and multiple N-terminal serine residues of p53. Oncogene (2001) 1.15
HLA-G: a shield against inflammatory aggression. Trends Immunol (2001) 1.15
The "Sardinian" HLA-A30,B18,DR3,DQw2 haplotype constantly lacks the 21-OHA and C4B genes. Is it an ancestral haplotype without duplication? Immunogenetics (1989) 1.14
HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition. Int Immunol (2001) 1.12
HLA system and side effects of gold salts and D-penicillamine treatment of rheumatoid arthritis. Ann Rheum Dis (1982) 1.11
Probable heploid expression of HL-A antigens on human spermatozoon. Nature (1970) 1.10
Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinoma. Cancer Res (2001) 1.10
Rosette-forming T cells in human peripheral blood at different ages. Cell Immunol (1974) 1.10
First trimester prenatal diagnosis of 21-hydroxylase deficiency by linkage analysis to HLA-DNA probes and by 17-hydroxyprogesterone determination. Hum Genet (1986) 1.10
Analysis of HLA class I genes with restriction endonuclease fragments: implications for polymorphism of the human major histocompatibility complex. Proc Natl Acad Sci U S A (1983) 1.09
Implication of HLA-G molecule in heart-graft acceptance. Lancet (2000) 1.09
Identification of human granzyme B promoter regulatory elements interacting with activated T-cell-specific proteins: implication of Ikaros and CBF binding sites in promoter activation. Proc Natl Acad Sci U S A (1995) 1.07
The genetic structure of 3'untranslated region of the HLA-G gene: polymorphisms and haplotypes. Genes Immun (2009) 1.07
Drug-induced hemolysis. Annu Rev Med (1967) 1.06
Dense Alu clustering and a potential new member of the NF kappa B family within a 90 kilobase HLA class III segment. Nat Genet (1993) 1.06
DNA polymorphism of HLA class I and class II regions. Immunol Rev (1985) 1.06
Ketone-body production and oxidation in fasting obese humans. J Clin Invest (1974) 1.06